InsiderTape plots every Form 4 on the price chart and flags cluster buys, CEO conviction, and first buys in years the moment they file. Start a free 7-day trial, cancel anytime.
START FREE TRIAL →Kate Haviland, CHIEF EXECUTIVE OFFICER, is a corporate insider tracked by InsiderTape across 1 company. The public record shows 11 open-market SEC Form 4 transactions: 1 purchase worth $48K and 10 sales worth $3.5M, reported from Sep 13, 21 to Apr 1, 25. Over this period they have been a net seller.
| Date | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Apr 1, 25 | BPMCBlueprint Medicines Corp | SELL | 1.2K | $88.59 | $105K |
| Mar 5, 25 | BPMCBlueprint Medicines Corp | SELL | 16.2K | $88.80 | $1.4M |
| Jan 21, 25 | BPMCBlueprint Medicines Corp | SELL | 1.4K | $110.24 | $159K |
| Nov 29, 24 | BPMCBlueprint Medicines Corp | SELL | 1.7K | $97.76 | $169K |
| Mar 7, 24 | BPMCBlueprint Medicines Corp | SELL | 12.5K | $90.69 | $1.1M |
| Mar 6, 23 | BPMCBlueprint Medicines Corp | SELL | 6.4K | $45.72 | $294K |
| Nov 3, 22 | BPMCBlueprint Medicines Corp | BUY | 1.1K | $43.98 | $48K |
| Mar 7, 22 | BPMCBlueprint Medicines Corp | SELL | 1.0K | $56.18 | $59K |
| Mar 3, 22 | BPMCBlueprint Medicines Corp | SELL | 1.7K | $60.27 | $104K |
| Dec 13, 21 | BPMCBlueprint Medicines Corp | SELL | 411 | $99.65 | $40K |
| Sep 13, 21 | BPMCBlueprint Medicines Corp | SELL | 417 | $101.11 | $41K |